Effect | Decrease |
Trial Design | Randomized trial |
Trial Length | 1-6 months |
Number of Subjects | 17 |
Sex | Female |
Age Range | 45-64 |
Body Types | Overweight, Average |
As assessed by ultrasound, red clover extract (40-80mg isoflavones) appears to increase arterial compliance by up to 23% in otherwise healthy postmenopausal women despite no influence on circulating lipids relative to placebo group (randomization had 5-fold more women in active treatment than placebo, and the sample size was only 17).Funding issues for this study:
(Rating of C given to this study due to the low sample in placebo group and a high dropout rate of 35%)
Supplies provided by Novagen, study not funded by Novagen